Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

被引:0
|
作者
Antoinette MaassenVanDenBrink
Gisela M. Terwindt
Arn M. J. M. van den Maagdenberg
机构
[1] Erasmus MC,Department of Internal Medicine, Division of Vascular Medicine and Pharmacology
[2] Leiden University Medical Centre,Department of Neurology
[3] Leiden University Medical Centre,Department of Human Genetics
来源
Genome Medicine | / 10卷
关键词
Calcitonin Gene-related Peptide (CGRP); Chronic Migraine; Erenumab; Fremanezumab; Receptor Activity-modifying Proteins (RAMP1);
D O I
暂无
中图分类号
学科分类号
摘要
Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
引用
收藏
相关论文
共 50 条
  • [31] Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine
    Crowley, Brendan M.
    Stump, Craig A.
    Nguyen, Diem N.
    Potteiger, Craig M.
    McWherter, Melody A.
    Paone, Daniel V.
    Quigley, Amy G.
    Bruno, Joseph G.
    Cui, Dan
    Culberson, J. Christopher
    Danziger, Andrew
    Fandozzi, Christine
    Gauvreau, Danny
    Kemmerer, Amanda L.
    Menzel, Karsten
    Moore, Eric L.
    Mosser, Scott D.
    Reddy, Vijay
    White, Rebecca B.
    Salvatore, Christopher A.
    Kane, Stefanie A.
    Bell, Ian M.
    Selnick, Harold G.
    Fraley, Mark E.
    Burgey, Christopher S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4777 - 4781
  • [32] Ubrogepant: An Oral Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist for Abortive Migraine Treatment
    Nedd, Madell
    Garland, Scott
    Falk, Nathan
    Wilk, Ashley
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (03) : 346 - 351
  • [33] Effectiveness of Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Treatment: A Meta-Analysis
    Pak, Kyoungjune
    Kim, Jiyoung
    Lee, Gha-Hyun
    Cho, Jae Wook
    Kim, Hyun-Woo
    EUROPEAN NEUROLOGY, 2022, 85 (03) : 195 - 201
  • [34] Calcitonin Gene-Related Peptide Targeted Therapy for Migraine
    Tepper, Deborah E.
    HEADACHE, 2016, 56 (02): : 447 - 448
  • [35] Calcitonin gene-related peptide causes migraine aura
    Al-Khazali, Haidar M.
    Ashina, Hakan
    Wiggers, Astrid
    Rose, Kathrine
    Iljazi, Afrim
    Christensen, Rune Haeckert
    Schytz, Henrik Winther
    Amin, Faisal Mohammad
    Ashina, Messoud
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [36] Hypersensitivity to calcitonin gene-related peptide in chronic migraine
    Iljazi, Afrim
    Ashina, Hakan
    Zhuang, Zixuan Alice
    Lopez, Cristina Lopez
    Snellman, Josefin
    Ashina, Messoud
    Schytz, Henrik Winther
    CEPHALALGIA, 2021, 41 (06) : 701 - 710
  • [37] Calcitonin gene-related peptide causes migraine aura
    Haidar M. Al-Khazali
    Håkan Ashina
    Astrid Wiggers
    Kathrine Rose
    Afrim Iljazi
    Rune Häckert Christensen
    Henrik Winther Schytz
    Faisal Mohammad Amin
    Messoud Ashina
    The Journal of Headache and Pain, 24
  • [38] Calcitonin gene-related peptide — beyond migraine prophylaxis
    Jes Olesen
    Messoud Ashina
    Nature Reviews Neurology, 2019, 15 : 562 - 564
  • [39] Treatment outcome of switching between monoclonal antibodies targeting calcitonin gene-related peptide in patients with migraine
    Youn, Michelle
    Lee, Mi Ji
    Kim, Manho
    CEPHALALGIA, 2023, 43 (1supp) : 229 - 229
  • [40] Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
    del Pilar Briceno-Casado, Maria
    David Gil-Sierra, Manuel
    Fenix-Caballero, Silvia
    FARMACIA HOSPITALARIA, 2020, 44 (05) : 212 - 217